Skip to content
Smart Money

Pharmaceuticals

GLAXO GlaxoSmithKline Pakistan Limited

Latest results: FY2025 · Dec 2025 Q2 FY2026 · Apr – Jun 2026

Last close · 16 Oct 2026

Rs 312.45 +0.19%

Quarterly · Q3 FY2021 – Q2 FY2026

GlaxoSmithKline Pakistan Limited (GLAXO) quarterly cash flow statement

Operating activities generated Rs 2.6 bn of cash in Q2 FY2026 (Apr – Jun 2026), down 33.0% on Q2 FY2025, 71% of the starting profit. Capital expenditure was Rs 402.2 mn, leaving free cash flow of Rs 2.2 bn. Dividends paid to shareholders came to Rs 3.8 bn. Overall, cash decreased by Rs 1.5 bn.

GLAXO cash flow statement (quarterly) (Rs bn)
Rs bn TTM to Jun 2026 Q2 FY2026 Apr – Jun 2026 Q1 FY2026 Jan – Mar 2026 Q4 FY2025 Oct – Dec 2025 Q3 FY2025 Jul – Sep 2025 Q2 FY2025 Apr – Jun 2025 Q1 FY2025 Jan – Mar 2025 Q4 FY2024 Oct – Dec 2024 Q3 FY2024 Jul – Sep 2024 Q2 FY2024 Apr – Jun 2024 Q1 FY2024 Jan – Mar 2024 Q4 FY2023 Oct – Dec 2023 Q3 FY2023 Jul – Sep 2023 Q2 FY2023 Apr – Jun 2023 Q1 FY2023 Jan – Mar 2023 Q4 FY2022 Oct – Dec 2022 Q3 FY2022 Jul – Sep 2022 Q2 FY2022 Apr – Jun 2022 Q1 FY2022 Jan – Mar 2022 Q4 FY2021 Oct – Dec 2021 Q3 FY2021 Jul – Sep 2021
Operating activities
Profit (cash-flow starting line, as reported) 17.6 3.6 4.3 6.4 3.2 3.5 3.5 4.9 2.8 1.9 1.0 1.9 (0.1) (0.3) 0.7 2.6 0.3 0.8 1.4 3.1 1.8
Depreciation & amortisation 1.5 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2
Net cash from operating activities 9.5 2.6 1.7 2.6 2.6 3.9 0.1 0.4 2.7 1.7 0.2 1.7 2.8 (0.6) (2.0) (2.2) 1.5 (2.1) 0.5 3.2 1.6
Investing activities
Capital expenditure (2.4) (0.4) (0.3) (1.0) (0.6) (0.5) (0.5) (1.2) (0.5) (0.3) (0.8) (0.6) (0.4) (0.3) (0.3) (0.8) (0.3) (0.3) (0.2) (0.6) (0.3)
Net cash from investing activities (2.1) (0.3) (0.3) (1.0) (0.5) (0.4) (0.4) (1.2) (0.4) (0.3) (0.8) (0.6) (0.3) (0.2) (0.3) (0.7) (0.2) (0.2) (0.2) 0.1 (0.2)
Financing activities
Dividends paid (5.4) (3.8) (0.0) (0.0) (1.6) (3.2) (0.0) 0.0 0.0 (0.0) (0.0) (1.8) (0.0) (0.0) 0.0 (0.0) (0.0) (0.3) (0.0) (0.0) (0.0)
Borrowings raised / (repaid) (0.1) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 0.0 (0.0) (0.0) (0.0) (0.0)
Net cash from financing activities (5.4) (3.8) (0.0) (0.0) (1.6) (3.2) (0.0) (0.0) (0.0) (0.0) (0.0) (1.9) (0.0) (0.0) (0.0) (0.0) (0.0) (0.3) (0.0) (0.0) (0.0)
Net change in cash 1.9 (1.5) 1.3 1.6 0.5 0.3 (0.3) (0.8) 2.2 1.4 (0.5) (0.8) 2.5 (0.8) (2.3) (2.9) 1.3 (2.7) 0.3 3.3 1.4
Key figures
Free cash flow (operating cash flow − capex) 7.1 2.2 1.3 1.6 2.0 3.4 (0.4) (0.8) 2.2 1.4 (0.6) 1.0 2.4 (0.9) (2.4) (3.0) 1.3 (2.4) 0.3 2.6 1.3
GLAXO cash flow statement — year-on-year change (Rs mn)
Rs mn Q2 FY2026 Apr – Jun 2026 Q1 FY2026 Jan – Mar 2026 Q4 FY2025 Oct – Dec 2025 Q3 FY2025 Jul – Sep 2025 Q2 FY2025 Apr – Jun 2025 Q1 FY2025 Jan – Mar 2025 Q4 FY2024 Oct – Dec 2024 Q3 FY2024 Jul – Sep 2024 Q2 FY2024 Apr – Jun 2024 Q1 FY2024 Jan – Mar 2024 Q4 FY2023 Oct – Dec 2023 Q3 FY2023 Jul – Sep 2023 Q2 FY2023 Apr – Jun 2023 Q1 FY2023 Jan – Mar 2023 Q4 FY2022 Oct – Dec 2022 Q3 FY2022 Jul – Sep 2022 Q2 FY2022 Apr – Jun 2022 Q1 FY2022 Jan – Mar 2022 Q4 FY2021 Oct – Dec 2021 Q3 FY2021 Jul – Sep 2021
Operating activities
Profit (cash-flow starting line, as reported) +4.3% +21.8% +31.8% +16.5% +88.3% +266.7% +153.6% — — +44.7% -26.7% -133.8% -138.3% -52.2% -14.6% -84.0% -44.0% +22.7% +171.0% -4.9%
Depreciation & amortisation +12.3% +16.8% +28.0% +29.7% +19.7% +12.8% +23.3% +14.4% +27.1% +28.0% -6.2% +19.4% +9.0% +10.3% +38.3% +2.4% -2.2% +6.0% -23.3% +9.1%
Net cash from operating activities -33.0% +1,475.3% +479.2% -1.9% +132.7% -56.2% -73.1% -5.5% — — — +85.0% — -533.9% -168.9% -5.3% -265.5% — +27.0% -52.3%
Investing activities
Capital expenditure -14.8% -27.5% -14.7% +33.0% +59.0% -42.5% +86.9% +14.8% +15.3% +135.7% -21.3% +55.8% -3.7% +85.6% +44.5% -5.4% +0.1% -5.1% +15.0% -40.0%
Net cash from investing activities — — — — — — — — — — — — — — -718.3% — — — — —
Financing activities
Dividends paid +20.1% +702.3% — — +240,666.8% -60.7% -100.0% -100.0% +145.7% — +125,934.8% -89.2% -99.8% -100.0% -17.3% +2,346.4% -83.3% -91.5% -71.6% -99.9%
Borrowings raised / (repaid) — — — — — — — — — — — -2,874.8% — — — — — — — —
Net cash from financing activities — — — — — — — — — — — — — — — — — — — —
Net change in cash -539.0% — — -78.3% -75.8% — — -10.3% — — — +91.1% — -865.3% -189.2% -6.5% — — +63.6% -8.6%
Key figures
Free cash flow (operating cash flow − capex) -35.5% — — -9.2% +148.8% — -175.9% -8.8% — — — +90.9% — -940.5% -215.5% -5.3% -334.9% — +30.0% -54.2%

Change against the same quarter a year earlier; shown when the earlier figure is positive.

Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets; "—" = not reported. TTM = the latest four quarters added together. Updated 16 Oct 2026.

All reported line items 42
GLAXO cash flow statement — all reported line items (Rs mn)
Rs mn Q2 FY2026 Apr – Jun 2026 Q1 FY2026 Jan – Mar 2026 Q4 FY2025 Oct – Dec 2025 Q3 FY2025 Jul – Sep 2025 Q2 FY2025 Apr – Jun 2025 Q1 FY2025 Jan – Mar 2025 Q4 FY2024 Oct – Dec 2024 Q3 FY2024 Jul – Sep 2024 Q2 FY2024 Apr – Jun 2024 Q1 FY2024 Jan – Mar 2024 Q4 FY2023 Oct – Dec 2023 Q3 FY2023 Jul – Sep 2023
Profit/(Loss) - Starting Line - Cash Flow 3,643.7 4,288.0 6,423.2 3,244.7 3,495.1 3,520.1 4,874.1 2,785.3 1,856.4 959.9 1,921.8 (95.4)
Non-cash Items & Reconciliation Adjustments - Cash Flow (223.7) 498.0 1,182.9 (346.8) 920.6 414.0 434.1 308.7 332.4 363.8 409.4 70.0
Other Non-Cash Items & Reconciliation Adjustments - Cash Flow - to Reconcile (200.4) 134.8 1,086.0 (680.1) 798.2 100.0 380.3 164.8 156.0 124.8 210.1 (101.0)
Financial Income/(Expense) - Cash Flow - to Reconcile (344.0) 7.6 (297.7) 6.9 (188.3) 4.1 (272.4) (110.0) (96.8) (40.4) (36.8) (30.3)
Depreciation, Depletion & Amortization including Impairment - Cash Flow - to Reconcile 383.7 373.1 401.8 352.8 341.7 319.4 313.9 272.1 285.4 283.2 254.6 237.9
Depreciation & Depletion - Property, Plant & Equipment - Cash Flow - to Reconcile 383.7 373.1 401.8 352.8 341.7 319.4 313.9 272.1 285.4 283.2 254.6 237.9
Assets Sale - Gain/(Loss) - Cash Flow - to Reconcile (63.1) (17.6) (7.2) (26.4) (31.0) (9.4) 12.3 (18.2) (12.2) (3.8) (18.5) (36.6)
Income Taxes - Paid/(Reimbursed) - Cash Flow 1,660.5 2,761.6 2,945.1 1,193.7 2,197.7 947.8 1,374.6 620.4 428.2 274.4 361.9 186.0
Interest & Dividends - Received - Total - Cash Flow 355.7 4.3 309.0 4.5 199.8 4.8 265.6 119.9 103.9 49.5 36.8 30.0
Cash Flow from Operating Activities before Changes in Working Capital 2,115.2 2,028.7 4,969.9 1,708.7 2,417.9 2,991.1 4,199.2 2,593.5 1,864.6 1,098.7 2,006.0 (181.4)
Working Capital - Increase/(Decrease) - Cash Flow 472.4 (376.6) (2,381.3) 916.9 1,444.9 (2,886.2) (3,752.3) 83.6 (204.7) (859.1) (346.8) 3,013.6
Accounts Receivables - Decrease/(Increase) - Cash Flow 2,572.6 (1,706.1) (2,108.0) 849.2 1,821.3 (1,330.2) (1,596.5) (724.7) 388.3 (905.0) (556.8) (244.3)
Inventories - Decrease/(Increase) - Cash Flow (2,617.2) (241.6) 3,571.8 (2,545.7) (1,334.7) (2,430.4) 4,246.8 (1,089.6) (2,300.7) (1,221.9) 1,439.2 (433.0)
Other Assets - Decrease/(Increase) - Cash Flow 66.2 (156.3) 21.1 97.6 (115.1) (17.0) (93.7) 189.4 (16.2) (39.3) (84.2) 112.5
Accounts Payable and Accrued Expenses - Increase/(Decrease) - Cash Flow 448.6 1,708.4 (3,868.4) 2,513.0 1,017.6 895.1 (6,314.4) 1,691.2 1,752.9 1,288.6 (1,212.3) 3,566.2
Other Liabilities - Increase/(Decrease) -Total - Cash Flow 2.2 19.0 2.3 2.9 55.9 (3.7) 5.5 17.3 (29.0) 18.4 67.3 12.2
Net Cash Flow from Operating Activities 2,587.5 1,652.1 2,588.6 2,625.7 3,862.8 104.9 447.0 2,677.2 1,659.9 239.6 1,659.2 2,832.2
Capital Expenditures - Net - Cash Flow 264.1 308.0 989.7 548.8 351.8 416.8 1,189.2 425.2 257.6 769.1 583.7 345.1
Property, Plant & Equipment - Purchased/(Sold) - Net - Cash Flow 264.1 308.0 989.7 548.8 351.8 416.8 1,189.2 425.2 257.6 769.1 583.7 345.1
Property, Plant & Equipment - Purchased - Cash Flow 402.2 335.4 1,034.9 613.1 472.1 462.6 1,213.5 461.0 296.8 803.9 649.1 401.5
Property, Plant & Equipment Sold - Cash Flow 138.1 27.4 45.2 64.3 120.3 45.8 24.4 35.8 39.3 34.9 65.4 56.4
Capital Expenditures - Total 402.2 335.4 1,034.9 613.1 472.1 462.6 1,213.5 461.0 296.8 803.9 649.1 401.5
Net Cash Flow from Investing Activities (264.1) (308.0) (989.7) (548.8) (351.8) (416.8) (1,189.2) (425.2) (257.6) (769.1) (583.7) (345.1)
Dividends Paid - Cash - Total - Cash Flow 3,794.4 1.4 0.7 1,582.2 3,158.9 0.2 0.0 0.0 1.3 0.4 1,841.4 3.2
Dividends - Common - Cash Paid 3,794.4 1.4 0.7 1,582.2 3,158.9 0.2 0.0 0.0 1.3 0.4 1,841.4 3.2
Debt - Long-Term & Short-Term - Issuance/(Retirement) - Total - Cash Flow (13.3) (25.0) (13.4) (13.1) (14.1) (13.8) (10.3) (29.4) (3.5) (7.9) (13.2) (6.0)
Debt - Issued/Reduced - Long-Term - Cash Flow (13.3) (25.0) (13.4) (13.1) (14.1) (13.8) (10.3) (29.4) (3.5) (7.9) (13.2) (6.0)
Lease liabilities - Issued/(Reduced) - Cash Flow (13.3) (25.0) (13.4) (13.1) (14.1) (13.8) (10.3) (29.4) (3.5) (7.9) (13.2) (6.0)
Debt - Reduced - Long-Term - Cash Flow 13.3 25.0 13.4 13.1 14.1 13.8 10.3 29.4 3.5 7.9 13.2 6.0
Lease liabilities - Reduced - Cash flow represents cash outflow due to the repayment of lease liability/debt of the company. It includes finance leases, capitalized lease, and hire-purchase agreement. Applicable to all industries. If Lease liability issue 13.3 25.0 13.4 13.1 14.1 13.8 10.3 29.4 3.5 7.9 13.2 6.0
Net Cash Flow from Financing Activities (3,807.7) (26.4) (14.1) (1,595.2) (3,172.9) (14.0) (10.3) (29.4) (4.8) (8.3) (1,854.6) (9.3)
Net Change in Cash - Total (1,484.3) 1,317.7 1,584.8 481.7 338.1 (325.9) (752.5) 2,222.5 1,397.5 (537.7) (779.2) 2,477.8
Net Cash from Continuing Operations (1,484.3) 1,317.7 1,584.8 481.7 338.1 (325.9) (752.5) 2,222.5 1,397.5 (537.7) (779.2) 2,477.8
Net Cash - Beginning Balance 9,909.9 8,592.1 7,007.3 6,525.6 6,187.6 6,513.4 7,266.0 4,470.5 3,073.0 3,610.8 3,817.0 1,339.1
Net Cash - Ending Balance 8,425.6 9,909.9 8,592.1 7,007.3 6,525.6 6,187.6 6,513.4 6,693.0 4,470.5 3,073.0 3,037.8 3,817.0
Income Taxes - Paid/(Reimbursed) - Cash Flow - Supplemental 1,660.5 2,761.6 2,945.1 1,193.7 2,197.7 947.8 1,374.6 620.4 428.2 274.4 361.9 186.0
Interest & Dividends - Received - Cash Flow - Supplemental 355.7 4.3 309.0 4.5 199.8 4.8 265.6 119.9 103.9 49.5 36.8 30.0
CF from Optg Activities before Change in WC & Int Payments 2,115.2 2,028.7 4,969.9 1,708.7 2,417.9 2,991.1 4,199.2 2,593.5 1,864.6 1,098.7 2,006.0 (181.4)
Depreciation, Depletion & Amortization - Cash Flow 383.7 373.1 401.8 352.8 341.7 319.4 313.9 272.1 285.4 283.2 254.6 237.9
Free Cash Flow to Equity 2,310.2 1,319.1 1,585.5 2,063.8 3,496.9 (325.7) (752.5) 2,222.5 1,398.8 (537.3) 1,062.2 2,481.1
Free Cash Flow Net of Dividends (1,609.0) 1,315.3 1,553.0 430.4 231.8 (357.9) (766.6) 2,216.1 1,361.7 (564.7) (831.3) 2,427.5
Free Cash Flow 2,185.4 1,316.7 1,553.7 2,012.6 3,390.7 (357.8) (766.6) 2,216.1 1,363.0 (564.3) 1,010.1 2,430.7

Every line the company reported, in the original order and wording, without regrouping or signs changed. Latest 12 periods; the table above goes back further.